1-[4-(difluoromethoxy)phenyl]-2-[6-[1-methyl-5-(morpholin-4-ylmethyl)pyrazol-4-yl]isoquinolin-3-yl]ethanone
C27H26F2N4O3 — CID 147763179
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-(difluoromethoxy)phenyl]-2-[6-[1-methyl-5-(morpholin-4-ylmethyl)pyrazol-4-yl]isoquinolin-3-yl]ethanone
1-[4-(difluoromethoxy)phenyl]-2-[6-[1-methyl-5-(morpholin-4-ylmethyl)pyrazol-4-yl]isoquinolin-3-yl]ethanone (PubChem CID 147763179) has the molecular formula C27H26F2N4O3 and a molecular weight of 492.53 g/mol. Its IUPAC name is 1-[4-(difluoromethoxy)phenyl]-2-[6-[1-methyl-5-(morpholin-4-ylmethyl)pyrazol-4-yl]isoquinolin-3-yl]ethanone.
Molecular Properties
| Compound Name | 1-[4-(difluoromethoxy)phenyl]-2-[6-[1-methyl-5-(morpholin-4-ylmethyl)pyrazol-4-yl]isoquinolin-3-yl]ethanone |
|---|---|
| PubChem CID | 147763179 |
| Molecular Formula | C27H26F2N4O3 |
| Molecular Weight | 492.53 g/mol |
| Exact Mass | 492.20 |
| IUPAC Name | 1-[4-(difluoromethoxy)phenyl]-2-[6-[1-methyl-5-(morpholin-4-ylmethyl)pyrazol-4-yl]isoquinolin-3-yl]ethanone |
| SMILES | Cn1ncc(-c2ccc3cnc(CC(=O)c4ccc(OC(F)F)cc4)cc3c2)c1CN1CCOCC1 |
| InChI | InChI=1S/C27H26F2N4O3/c1-32-25(17-33-8-10-35-11-9-33)24(16-31-32)19-2-3-20-15-30-22(13-21(20)12-19)14-26(34)18-4-6-23(7-5-18)36-27(28)29/h2-7,12-13,15-16,27H,8-11,14,17H2,1H3 |
| InChIKey | HEMCABGKWJUQDM-UHFFFAOYSA-N |
| XLogP | 4.49 |
| TPSA | 69.48 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 492.53 |
| LogP ≤ 5 | 4.49 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 147763179 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.